We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

This study has been withdrawn prior to enrollment.
(No funding was available for the cost of the IV N-acetylcysteine (NAC).)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01138137
First Posted: June 7, 2010
Last Update Posted: April 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Edward Neuwelt, OHSU Knight Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)